Business Alignment PCL (BKK:BIZ) 3-Year EBITDA Growth Rate : 46.30% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Business Alignment PCL 3-Year EBITDA Growth Rate?

Business Alignment PCL's EBITDA per Share for the three months ended in Mar. 2024 was ฿0.09.

During the past 12 months, Business Alignment PCL's average EBITDA Per Share Growth Rate was 31.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 46.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 27.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Business Alignment PCL was 77.00% per year. The lowest was 1.80% per year. And the median was 32.35% per year.

Competitive Comparison of Business Alignment PCL's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Business Alignment PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Business Alignment PCL's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Business Alignment PCL's 3-Year EBITDA Growth Rate falls into.

Business Alignment PCL 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Business Alignment PCL (BKK:BIZ) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Business Alignment PCL 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Business Alignment PCL's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Business Alignment PCL (BKK:BIZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Business Alignment PCL (BKK:BIZ) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

North Sathorn Road, 92/45 Sathorn Thani Building 2, 16th Floor,, Silom Sub-District, Bangrak District, Bangkok, THA, 10500

Website

https://www.bizalignment.com

Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through i) the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment and ii) Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically operates through the region of Thailand.

Business Alignment PCL (BKK:BIZ) Headlines

No Headlines